Progenics Pharmaceuticals

Media Advisory - BMO Capital Markets to Host 8th Annual Focus On Healthcare Conference (PR Newswire)

yahoo.com     Jul 30, 2008   2 related          

BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group , will hold its eighth annual two-day conference, Focus On Healthcare, Tuesday, August 5 and Wednesday, August 6, at the Millennium Broadway...                    

comments

                   

Cancer Vaccine Contenders Lurk Among the Casualties

tmcnet.com     Jul 28, 2008   8 related          

Between the negative Phase III news on Oxford BioMedica plc's TroVax and the positive Phase III news on Biovest International Inc.'s BiovaxID, it's been a big month for cancer vaccines. But despite all the failures and amid all...                    

comments

Generic Heartburn at Wyeth (at Motley Fool)

yahoo.com     Jul 25, 2008          

By Brian Orelli July 25, 2008 Comments (0) Wyeth (NYSE: WYE) has a serious case of generic-induced heartburn that's not likely to go away any time soon. Revenue from its heartburn drug Protonix dropped 59% year over year after...                    

comments

Wyeth Earnings Call scheduled for 8:00 am ET today (CCBN)

yahoo.com     Jul 23, 2008   2 related          

Wyeth Earnings Conference Call (Q2 2008) Scheduled to start Wed, Jul 23, 2008, 8:00 am Eastern -- this event is ongoing now-- After the event has finished, the audio will be available from this page until Fri, Jul 24, 2009...                    

comments

                   

BUYINS.NET: AVR, OVEN, PGNX, THRX, URST, ADBRF Have Been Added To Naked Short List Today

tmcnet.com     Jul 16, 2008   13 related          

BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: Aventine Renewable Energy Holdings Inc. (NYSE: AVR), TurboChef Technologies Inc....                    

comments

                   

Wyeth And Progenics Receive Approval From European Commission For Relistor For Opioid-Induced...

medicalnewsblog.info     Jul 12, 2008   1 related          

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), announced that the companies have received marketing approval for RELISTOR™ (methylnaltrexone bromide) subcutaneous...                    

comments

Friedman Billings Dropping Coverage for PROGENICS PHARMACEUTICALS INC

pharmiweb.co.uk     Jul 11, 2008   2 related          

Released : Friday, July 11, 2008 1:27 PM Company: PROGENICS PHARMACEUTICALS INC Report Date: July 09, 2008 Report Headline: "Dropping Coverage" Current Recommendation: Previous Recommendation: UNDERPERFORM Research Firm:...                    

comments

Seattle Genetics Has What Others Want (at Motley Fool)

yahoo.com     Jul 10, 2008   8 related          

By Brian Lawler July 10, 2008 Comments (0) Few things are better in biotech than holding the rights to a sought-after technology. Earlier in the week, budding biopharma Seattle Genetics (Nasdaq: SGEN) inked a deal with Daiichi...                    

comments

genengnews.com: Genetic Engineering genengnews.com

AP Pharma names new president and CEO

pharmaceutical-business-review.com     Jul 9, 2008   23 related          

AP Pharma has appointed Ronald Prentki as its new president, CEO and a member of the company's board of directors. Mr Prentki succeeds Gregory Turnbull, who will remain a company director, a member of the board's executive...                    

comments

                   

InvestSource Inc.: IVI Communications Consummates Loan and Security Agreement

tmcnet.com     Jul 7, 2008   1 related          

Stocks in the News: IVI Communications, Inc. ("IVI") (OTCBB: IVCM), Titan Global Holdings, Inc. (Pink Sheets: TTGL), Wyeth Pharmaceuticals (NYSE: WYE), Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), Harsco Corporation (NYSE:...                    

comments

1 2 3 4 5 next »